Casdin Amplify Fund, LP - 18 Jun 2024 Form 3 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Reporting relationship: Director
Issuer ticker: LAB
Reported as of: 18 Jun 2024
Net transaction value: $0
SEC form: 3
Accepted by SEC: 26 Jun 2024, 20:08:37 UTC
Source filing: View source filing
Reporting owner signature: Casdin Amplify Fund, LP, By: Casdin Partners GP, LLC, its General Partner, By: /s/ Eli Casdin, Managing Member

Key filing fact

Casdin Amplify Fund, LP filed Form 3 for STANDARD BIOTOOLS INC. (LAB) on 26 Jun 2024.

Key facts

This page summarizes Casdin Amplify Fund, LP's Form 3 filing for STANDARD BIOTOOLS INC. (LAB).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 26 Jun 2024, 20:08.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 545,000
Date: 18 Jun 2024
Ownership: See footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The securities are owned directly by Casdin Amplify Fund, LP ("Amplify") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Amplify ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of Amplify (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.

SEC remarks

Eli Casdin has been deputized to represent the Reporting Person on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), the Reporting Person may be deemed a director by deputization of the Issuer. The Reporting Person disclaims beneficial ownership in the securities reported on this Form 3 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.